Daptomycin for Treatment of S. Epidermidis Endocarditis in an Extremely Preterm Neonate-Outcome and Perspectives

Children (Basel). 2022 Mar 24;9(4):457. doi: 10.3390/children9040457.

Abstract

With a considerable morbidity and mortality burden, infective endocarditis still represents a challenge for clinicians. This is a case of persistent Staphylococcus epidermidis endocarditis in an extremely preterm newborn. The infection, initially treated with vancomycin, was successfully cured with daptomycin. Its use was safe and effective, ensuring a complete remission without adverse effects.

Keywords: Staphylococcus epidermidis; daptomycin; endocarditis; neonate; preterm.

Publication types

  • Case Reports